SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AMEV-Applied Molecular Evolution
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
164 16 0 AMEV
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
64They're supposed to disclose a couple of internal pipe candidates on 1/17, srkrw-1/2/2003
63Wonder what this might be about: >>SAN DIEGO--(BUSINESS WIRE)--Jan. 2, 20tuck-1/2/2003
62SAN DIEGO--(BUSINESS WIRE)--Dec. 17, 2002--Applied Molecular Evolution, Inc. (AMnigel bates-12/17/2002
61Looks like both to me. If the process isn't random, then AMEV has no claim.scaram(o)uche-12/4/2002
60Looks as though you're right - Message 18299156nigel bates-12/4/2002
59I'd guess it's more for manufacturing antibodies or "planti-bodies&rkrw-12/4/2002
58New kid on the AMEV / MAXY block ? Message 18298743 <i>...Syngenta and Dinigel bates-12/4/2002
57Thanks, for both answers! (eom)scaram(o)uche-11/12/2002
56They bought back some shares: amevolution.com Applied Molecular Evolution, Inrkrw-11/12/2002
55Do you know why the weighted shares out for 3 months is lower than for nine montscaram(o)uche-11/12/2002
54Won't it hurt company morale if they don't? :-)rkrw-11/12/2002
53Oh, I see. They need to have one of the most beautiful of HQs in the most beautscaram(o)uche-11/12/2002
52$10M restricted cash from 10Q: 3. Commitments On August 17, 2001, we entered rkrw-11/12/2002
51I don't follow them. Why is burn running at $20M/year, when (if?) they don&scaram(o)uche-11/12/2002
50Results didn't look quite this bad to me - finance.yahoo.com Any ideas ?nigel bates-11/12/2002
49AMEV beats numbers; revenue by 25%, EPS by a lot (estimates were for a loss of otuck-11/5/2002
48...Achievement of a Milestone in Collaboration with Lilly SAN DIEGO--(BUSINESS nigel bates-10/16/2002
47BVF is adding... Insider & restricted shareholder transactions 2002-09-13rkrw-10/3/2002
46AMEV licenses CRXL's PER.C6 - Message 18056207nigel bates-10/1/2002
45SAN DIEGO--(BUSINESS WIRE)--Sept. 30, 2002--Novasite Pharmaceuticals, Inc. (Novanigel bates-10/1/2002
44Difference in management style? Looks like out with science and in with the capkeokalani'nui-9/16/2002
43Wholesale board changes, see also - Message 17995064 SAN DIEGO--(BUSINESS WIRE)nigel bates-9/16/2002
42Applied Molecular Evolution Signs Kauffman Licensing Agreement with NascaCell nigel bates-9/16/2002
41SAN DIEGO--(BW HealthWire)--May 8, 2002--Applied Molecular Evolution, Inc. (AME)nigel bates-5/8/2002
40SAN DIEGO--(BW HealthWire)--April 1, 2002--Novasite Pharmaceuticals Inc. (Novasinigel bates-4/2/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News